COVID-19: неврологические последствия

Файл статьи: 
Иконка PDF health-risk-analysis-2021-2-16.pdf
УДК: 
614.1
DOI: 
10.21668/health.risk/2021.2.16
Авторы: 

П.С. Спенсер1, Г. Роман2, А. Бюге3, А. Гехт4, Ж. Рейс5

Организация: 

1Орегонский университет здоровья и науки, США, Орегон, 97201, г. Портланд
2Методистская больница Хьюстона, США, TX 77030, г. Хьюстон, Фаннин стрит, 6560
3Университет Клод Бернард Лион-1, Франция, 69622, г. Вийербан, Бульвар 11 ноября 1918, 43
4Научно-практический психоневрологический центр имени З.П. Соловьева, Россия, 115419, г. Москва, ул. Донская, 43
5Университет Страсбурга, Франция, 67205, г. Страсбург, Оберхаусберген, ул. Рю де Луар, 3

Аннотация: 

COVID-19 – это, в первую очередь, респираторное заболевание человека, вызываемое коронавирусом SARS-CoV-2. Но в большинстве случаев оно затрагивает и нервную систему: его последствия могут ощущаться в течение многих месяцев. Последствия острой фазы заболевания COVID-19 – ослабевающие и возвращающиеся неврологические и нервно-психиатрические симптомы как у детей, так и у взрослых, включая и тех, кто переболел в довольно легкой форме.
Вследствие того, что длительное негативное воздействие COVID-19 на центральную и периферийную нервную систему невозможно игнорировать, необходимо осуществлять мониторинг здоровья как бывших пациентов, так и общества в целом. В настоящее время настоятельным является не только глобальная иммунизация против SARS-CoV-2, но и возобновление прекращенных программ массовой вакцинации против других вирусных заболеваний (например, кори и полиомиелита), которые могут оказывать воздействие на нервную систему.

Ключевые слова: 
SARS-CoV-2, PASC: постковидный синдром (длительный COVID-19), вакцины.
COVID-19: неврологические последствия / П.С. Спенсер, Г. Роман, А. Бюге, А. Гехт, Ж. Рейс // Анализ риска здоровью. – 2021. – № 2. – С.168–176. DOI: 10.21668/health.risk/2021.1.16
Список литературы: 
  1. The proximal origin of SARS-CoV-2 / K.G. Andersen, A. Rambaut, W.I. Lipkin, E.C. Holmes, R.F. Garry // Nat Med. – 2020. – Vol. 26, № 4. – P. 450–452. DOI: 10.1038/s41591-020-0820-9
  2. Lawrence S.V. COVID-19 and China: A Chronology of Events (December 2019-January 2020). – USA: Congressional Research Service, 2020. – 47 p.
  3. Lu D. The hunt to find the coronavirus pandemic's patient zero // New Sci. – 2020. – Vol. 4, № 245. – P. 9. DOI: 10.1016/S0262-4079(20)30660-6
  4. Timing the SARS-CoV-2 index case in Hubei Province / J. Pekar, M. Worobey, N. Moshiri, K. Scheffler, J.O. Wertheim // Science. – 2021. – № 372. – P. 412–417. DOI: 10.1126/science.abf8003
  5. History of the COVID-19 pandemic: Origin, explosion, worldwide spreading / S. Platto, Y. Wang, J. Zhou, E. Carafoli // Biochem Biophys Res Commun. –2021. – № 538. – P. 14–23. DOI: 10.1016/j.bbrc.2020.10.087
  6. Platto S., Xue T., Carafoli E. COVID19: an announced pandemic // Cell Death Dis. – 2020. – № 11. – P. 799. DOI: 10.1038/s41419-020-02995-9
  7. Zaheer A. The first 50 days of COVID-19: A detailed chronological timeline and extensive review of literature documenting the pandemic // Surveying the COVID-19 Pandemic and its implications. – 2020. – P. 1–7. DOI: 10.1016/B978-0-12-824313-8.00001-2
  8. Bat coronaviruses in China / Y. Fan, K. Zhao, Z.L. Shi, P. Zhou // Viruses. – 2019. – Vol. 11, № 3. – P. 210. DOI: 10.3390/v1103021
  9. The spatial and cell-type distribution of SARS-CoV-2 Receptor ACE2 in the human and mouse brains / R. Chen, K. Wang, J. Yu, D. Howard, L. French, Z. Chen, C. Wen, Z. Xu // Front Neurol. – 2021. – Vol. 20, № 11. – P. 573095. DOI: 10.3389/fneur.2020.573095
  10. SARS-CoV-2 dissemination through peripheral nerves explains multiple organ injury / M. Fenrich, S. Mrdenovic, M. Balog, S. Tomic, M. Zjalic, A. Roncevic, D. Mandic, Z. Debeljak, M. Heffer // Front Cell Neurosci. – 2020. – Vol. 5, № 14. – 229. DOI: 10.3389/fncel.2020.00229
  11. Holappa M., Vapaatalo H., Vaajanen A. Many faces of renin-angiotensin system – focus on eye // Open Ophthalmol J. – 2017. – № 11. – P. 122–142. DOI: 10.2174/1874364101711010122
  12. Beneficial Effect of Mas Receptor Deficiency on Vascular Cognitive Impairment in the Presence of Angiotensin II Type 2 Receptor / A. Higaki, M. Mogi, J. Iwanami, L.‐J. Min, H.‐Y. Bai, B.‐S. Shan, M. Kukida, T. Yamauchi [et al.] // J Am Heart Assoc. – 2018. – Vol. 7, № 3. – P. e008121. DOI: 10.1161/JAHA.117.008121
  13. Body localization of ACE-2: On the trail of the keyhole of SARS-CoV-2 / F. Salamanna, M. Maglio, M.P. Landini, M. Fini // Front Med (Lausanne). – 2020. – Vol. 3, № 7. – P. 594495. DOI: 10.3389/fmed.2020.594495
  14. Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function / X.L. Wang, J. Iwanami, L.J. Min, K. Tsukuda, H. Nakaoka, H.-Y. Bai, B.-S. Shan, H. Kan-No [et al.] // NPJ Aging Mech Dis. – 2016. – Vol. 20, № 2. – P. 16024. DOI: 10.1038/npjamd.2016.24
  15. Analysis of risk actors in COVID-19 adult mortality in Russia / Y. Kirillov, S. Timofeev, A. Avdalyan, V.N. Nikolenko, L. Gridin, M.Y. Sinelnikov // J Prim Care Community Health. – 2021. – Vol. 12. – P. 21501327211008050. DOI: 10.1177/21501327211008050
  16. Comorbidity and its impact on patients with COVID-19 / A. Sanyaolu, C. Okorie, A. Marinkovic, R. Patidar, K. Younis, P. Desai, Z. Hosein, I. Padda [et al.] // SN Compr Clin Med. – 2020. – Vol. 25. – P. 1–8. DOI: 10.1007/s42399-020-00363-4
  17. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection / P. Verdecchia, C. Cavallini, A. Spanevello, A. Fabio // Eur J Intern Med. – 2020. – Vol. 76. – P. 14–20. DOI: 10.1016/j.ejim.2020.04.037
  18. Interactions of SARS-CoV-2 with the blood-brain barrier / M.A. Erickson, E.M. Rhea, R.C. Knopp, W.A. Banks // Int J Mol Sci. – 2021. – Vol. 6, № 22 (5). – P. 2681. DOI: 10.3390/ijms22052681
  19. Alomari S., Abou-Mrad Z., Bydon A. COVID-19 and the central nervous system // Clin Neurol Neurosurg. – 2020. – Vol. 198. – P. 106116. DOI: 10.1016/j.clineuro.2020.106116
  20. Neurological associations of COVID-19 / M.A. Ellul, L. Benjamin, B. Singh, S. Lant, B.D. Michael, A. Easton, R. Kneen, S. Defres [et al.] // Lancet Neurol. – 2020. – Vol. 19, № 9. – P. 767–783. DOI: 10.1016/S1474-4422(20)30221-0
  21. El-Sayed A., Aleya L., Kamel M. COVID-19: a new emerging respiratory disease from the neurological perspective // Environ Sci Pollut Res Int. – 2021. – Vol. 15. – P. 1–15. DOI: 10.1007/s11356-021-12969-9
  22. Frequent neurologic manifestations and encephalopathy-associated morbidity in COVID-19 patients / E.M. Liotta, A. Batra, J.R. Clark, N.A. Shlobin, S.C. Hoffman, Z.S. Orban, I.J. Koralnik [et al.] // Ann Clin Transl Neurol. – 2020. – Vol. 7, № 11. – P. 2221–2230. DOI: 10.1002/acn3.51210
  23. Central nervous system manifestations in COVID-19 patients: A systematic review and meta-analysis / S. Nazari, A. Azari Jafari, S. Mirmoeeni, S. Sadeghian, M. Eghbal Heidari, S. Sadeghian, F. Assarzadegan, S. Mahmoud Puormand [et al.] // Brain Behav. – 2021. – P. e02025. DOI: 10.1002/brb3.2025
  24. Decade of progress in motor functional neurological disorder: continuing the momentum / D.L. Perez, M.J. Edwards, G. Nielsen, K. Kozlowska, M. Hallett, W. Curt LaFrance Jr. // J Neurol Neurosurg Psychiatry. – 2021. – Vol. 92, № 6. – P. 668–667. DOI: 10.1136/jnnp-2020-323953
  25. Psychological morbidities and fatigue in patients with confirmed COVID-19 during disease outbreak: prevalence and associated biopsychosocial risk factors / R. Qi, W. Chen, S. Liu, P.M. Thompson, L.J. Zhang, F. Xia, F. Cheng, A. Hong [et al.] // medRxiv. – 2020. – № 11. – P. 1–21. DOI: 10.1101/2020.05.08.20031666
  26. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries / G.C. Román, P.S. Spencer, J. Reis, A. Buguet, M. El Alaoui Faris, S.M. Katrak, M. Láinez, M. Tulio Medina [et al.] // J Neurol Sci. – 2020. – Vol. 15, № 414. – P. 116884. DOI: 10.1016/j.jns.2020.116884
  27. Neurological involvement in the respiratory manifestations of COVID-19 patients / B.H. Tan, J.M. Liu, Y. Gui, S. Wu, J.-L. Suo, Y.-C. Li // Aging (Albany NY). – 2021. – Vol. 14, № 13 (3). – P. 4713–4730. DOI: 10.18632/aging.202665
  28. Wildwing T., Holt N. The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services // Ther Adv Chronic Dis. – 2021. – Vol. 12. – P. 2040622320976979. DOI: 10.1177/2040622320976979
  29. Epilepsy course during COVID-19 pandemic in three Italian epilepsy centers / C. Cabona, F. Deleo, L. Marinelli, D. Audenino, D. Arnaldi, F. Rossi, R. Di Giacomo, C. Buffoni [et al.] // Epilepsy Behav. – 2020. – Vol. 112. – P. 107375. DOI: 10.1016/j.yebeh.2020.107375
  30. Эпилепсия и COVID-19: ведение больных и оптимизация противоэпилептической терапии в условиях пандемии / Ф.К. Ридер, А.В. Лебедева, В.Р. Мкртчян, А.Б. Гехт // Журнал неврологии и психиатрии им. С.С. Корсакова. – 2020. – Vol. 120, № 10. – P. 100–107.
  31. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: A systematic review and individual patient data meta-analysis / B. Singh, S. Lant, S. Cividini, J.W.S. Cattrall, L. Goodwin, L. Benjamin, B. Michael, A. Khawaja [et al.] // Lancet. – 2021. – Vol. 27. – P. 95. DOI: 10.21.2139/ssrn.3834310
  32. Azghandi M., Kerachian M.A. Detection of novel coronavirus (SARS-CoV-2) RNA in peripheral blood specimens // J Transl Med. – 2020. – № 18. – P. 412. DOI: 10.1186/s12967-020-02589-1
  33. Neuropathology of COVID-19 (neuro-COVID): clinicopathological update / J.J. Lou, M. Movassaghi, D. Gordy, M.G. Olson, T. Zhang, M.S. Khurana, Z. Chen, M. Perez-Rosendahl [et al.] // Free Neuropathol. – 2021. – Vol. 2, № 2. DOI: 10.17879/freeneuropathology-2021-2993
  34. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms / B. Neumann, M.L. Schmidbauer, K. Dimitriadis, S. Otto, B. Knier, W.-D. Niesen, J.A. Hosp, A. Günther [et al.] // J Neurol Sci. – 2020. – Vol. 15, № 418. – P. 117090. DOI: 10.1016/j.jns.2020.117090
  35. Detection of SARS-CoV-2 in different types of clinical specimens / W. Wang, Y. Xu, R. Gao, R. Lu, K. Han, G. Wu, W. Tan // JAMA. – 2020. – Vol. 12, № 323 (18). – P. 1843–1844. DOI: 10.1001/jama.2020.3786
  36. Microvascular injury in the brains of patients with COVID-19 / M.H. Lee, D.P. Perl, G. Nair, W. Li, D. Maric, H. Murray, S.J. Dodd, A.P. Koretsky [et al.] // N Engl J Med. – 2021. Vol. 4, № 384 (5). – P. 481–483. DOI: 10.1056/NEJMc2033369
  37. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series / J. Matschke, M. Lütgehetmann, C. Hagel, J.P. Sperhake, A.S. Schröder, C. Edler, H. Mushumba, A. Fitzek [et al.] // Lancet Neurol. – 2020. – Vol. 19, № 11. – P. 919–929. DOI: 10.1016/S1474-4422(20)30308-2
  38. Brundin P., Nath A., Beckham J.D. Is COVID-19 a perfect storm for Parkinson's Disease? // Trends Neurosci. – 2020. – № 43. – P. 931–933. DOI: 10.1016/j.tins.2020.10.009
  39. Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequalae of COVID-19 // Nature. – 2021. – Vol. 594, № 7862. – P. 259–264. DOI: 10.1038/s41586-021-03553-9
  40. Carfì A., Bernabei R., Landi F. for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19 // JAMA. – 2020. – Vol. 11, № 324 (6). – P. 603–605. DOI: 10.1001/jama.2020.12603
  41. Miners S., Kehoe P.G., Love S. Cognitive impact of COVID-19: looking beyond the short term // Alzheimers Res Ther. – 2020. – № 12. – P. 170. DOI: 10.1186/s13195-020-00744-w
  42. Acute Transverse Myelitis (ATM): Clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 Vaccine (AZD1222) / G.C. Román, F. Gracia, A. Torres, A. Palacios, K. Gracia, D. Harris [et al.] // Front Immunol. – 2021. – Vol. 26, № 12. – P. 653786. DOI: 103389/fimmu.2021.653786
  43. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view / H. Simon Junior, T.M.S. Sakano, R.M. Rodrigues, A.P. Eisencraft, V.E. Lemos de Carvalho, C. Schvartsman, A.G.A. da Costa Reis // J Pediatr (Rio J). – 2021. – Vol. 97, № 2. – P. 140–159. DOI: 10.1016/j.jped.2020.08.004
  44. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records / M. Taquet, J.R. Geddes, M. Husain, S. Luciano, P.J. Harrison // Lancet Psychiat. – 2021. – № 8. – P. 416–427. DOI: 10.1016/s2215-0366(21)00084-5
  45. Risk factors for long-term consequences of COVID-19 in hospitalized adults in Moscow using the ISARIC Global follow-up protocol: Stop COVID cohort study / D. Munblit, P. Bobkov, E. Spiridonova, A. Shikhaleva, A. Gamirova, O. Blyuss, N. Nekliudov, P. Bugaev [et al.] // medRxiv. – 2021. – № 19. – P. 26. DOI: 10.1101/2021.02.17.21251895
  46. Torjeson I. Covid-19: Middle aged women face greater risk of debilitating long term symptoms // BMJ. – 2021. – № 372. – P. n829. DOI: 10.1136/bmj.n829
  47. Baig A.M. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers // J Med Virol. – 2021. – № 93. – P. 2555–2556. DOI: 10.1002/jmv.26624
  48. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An integrative classification / C. Fernández-de-Las-Peñas, D. Palacios-Ceña, V. Gómez-Mayordomo, M.L. Cuadrado, L.L. Florencio // Int J Environ Res Public Health. – 2021. – № 18. – P. 2621. DOI: 10.3390/ijerph18052621
  49. Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study // BMC Neurol. – 2011. – Vol. 24, № 11. – P. 37. DOI: 10.1186/1471-2377-11-37
  50. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies / M. Dani, A. Dirksen, P. Taraborrelli, M. Torocastro, D. Panagopoulos, R. Sutton, P.B. Lim // Clin Med J. – 2021. – № 21. – P. e63–e67. DOI: 10.7861/clinmed.2020-089
  51. Wijeratne T., Crewther S. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community // J Neurol Sci. – 2020. – № 419. – P. 117179. DOI: 10.1016/j.jns.2020.117179
  52. Sars-Cov-2: Underestimated damage to nervous system / L. Zhou, M. Zhang, J. Wang, J. Gao // Travel Med Infect Dis. – 2020. – № 36. – P. 101642. DOI: 10.1016/j.tmaid.2020.101642
  53. Hawkes C. Olfaction in neurodegenerative disorder // Adv Otorhinolaryngol. – 2006. – № 63. – P. 133–151. DOI: 10.1159/000093759
  54. APOE e4 Genotype predicts severe COVID-19 in the UK Biobank Community Cohort / C.L. Kuo, L.C. Pilling, J.L. Atkins, J.A.H. Masoli, J. Delgado, G.A. Kuchel, D. Melzer // J Gerontol A Biol Sci Med Sci. – 2020. – Vol. 15, № 75 (11). – P. 2231–2232. DOI: 10.1093/gerona/glaa131
  55. ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response / C. Wang, M. Zhang, G. Garcia Jr, E. Tian, Q. Cui, X. Chen, G. Sun, J. Wang [et al.] // Cell Stem Cell. – 2021. – № 28. – P. 331–342.e5. DOI: 10.1016/j.stem.2020.12.018
  56. Outbreak of Marburg virus disease in Johannesburg / J.S. Gear, G.A. Cassel, A.J. Gear, B. Trappler, L. Clausen, A.M. Meyers, M.C. Kew, T.H. Bothwell [et al.] // Br Med J. – 1975. – Vol. 29, № 4. – P. 489–493. DOI: 10.1136/bmj.4.5995.489
  57. Van Gelder R.N., Margolis T.P. Ebola and the ophthalmologist // Ophthalmology. – 2015. – № 122. – P. 2152–2154. DOI: 10.1016/j.ophtha.2015.08.027
  58. Persistence of Ebola Virus in ocular fluid during convalescence / J.B. Varkey, J.G. Shantha, I. Crozier, C.S. Kraft, G.M. Lyon, A.K. Mehta, G. Kumar, J.R. Smith [et al.] // N Engl J Med. – 2015. – № 372. – P. 2423–2427. DOI: 10.1056/NEJMoa1500306
  59. A dangerous measles future looms beyond the COVID-19 pandemic / D.N. Durrheim, J.K. Andrus, S. Tabassum, H. Bashour, D. Githanga, G. Pfaff [et al.] // Nat Med. – 2021. – Vol. 27, № 3. – P. 360–361. DOI: 10.1038/s41591-021-01237-5
  60. Fading measles immunity over time. Center for Infectious Disease Research and Policy [Электронный ресурс] // CIDRAP. – URL: https://www.cidrap.umn.edu/news-perspective/2020/09/news-scan-sep-02-2020 (дата обращения: 03.04.2021).
  61. Impact of COVID-19 on routine immunisation in South-East Asia and Western Pacific: Disruptions and solutions / R.C. Harris, Y. Chen, P. Côte, A. Ardillon, M.C. Nievera, A. Ong-Lim, S. Aiyamperumal, C.P. Chong [et al.] // Lancet Reg Health West Pac. – 2021. – № 10. – P. 100140. DOI: 10.1016/j.lanwpc.2021.100140
  62. The upsurge of SSPE--a reflection of national measles immunization status in Pakistan / S.H. Ibrahim, N. Amjad, A.F. Saleem, P. Chand, A. Rafique, K. Nuzhat Humayun // J Trop Pediatr. – 2014. – Vol. 60, № 6. – P. 449–453. DOI: 10.1093/tropej/fmu050
  63. Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system? / M. Desforges, A. Le Coupanec, P. Dubeau, A. Bourgouin, L. Lajoie, M. Dubé, P.J. Talbot // Viruses. – 2019. – Vol. 20, № 12 (1). – P. 14. DOI: 10.3390/v12010014
  64. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43 / M. Dubé, A. Le Coupanec, A.H.M. Wong, J.M. Rini, M. Desforges, P.J. Talbot // J Virol. – 2018. – Vol. 16, № 92 (17). – P. e00404-18. DOI: 10.1128/JVI.00404-18
Получена: 
26.05.2021
Принята: 
15.06.2021
Опубликована: 
30.06.2021

Вы здесь

Главная